BIORESTORATIVE THERAPIES INC
BRTX · NASDAQ
Updated at 2026-10-13 15:23:11
- Today's High
- $1.71
- Today’s Low
- $1.61
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.85
- Previous Close
- $1.75
- Volume
- 11.35K
- Market Cap
- $2.41M
- P/E Ratio
- --
- EPS
- $-15.98
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 40 MARCUS DRIVE, MELVILLE, NY, UNITED STATES, 11747
- Country
- US
- Listing Date
- 2001-07-11
- Fiscal Year End
- December
- Shares Outstanding
- 25.48M
- CIK
- 0001505497
- Website
- www.biorestorative.com
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols that primarily involve adult stem cells. The company is headquartered in Melville, New York.
Financial Metrics
Revenue
2026-03-31
$23.17K
2025-12-31
$19.6K
2025-09-30
$11.8K
2025-06-30
$303.3K
Operating Expenses
2026-03-31
$3.4M
2025-12-31
$3.84M
2025-09-30
$3.71M
2025-06-30
$3.59M
Net Income
2026-03-31
-$2.15M
2025-12-31
-$3.2M
2025-09-30
-$3.03M
2025-06-30
-$2.65M
Net Profit Margin
2026-03-31
-9.29K%
2025-12-31
-16.36K%
2025-09-30
-25.74K%
2025-06-30
-875.78%
Earnings Per Share
2026-03-31
$-0.12
2025-12-31
$-0.32
2025-09-30
$-0.33
2025-06-30
$-0.30
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-03-31
-$2.1M
2025-12-31
-$3.15M
2025-09-30
-$2.98M
2025-06-30
-$2.6M
Effective Tax Rate
2026-03-31
--
2025-12-31
--
2025-09-30
--
2025-06-30
--
| Item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | $23.17K | $19.6K | $11.8K | $303.3K |
| Operating Expenses | $3.4M | $3.84M | $3.71M | $3.59M |
| Net Income | -$2.15M | -$3.2M | -$3.03M | -$2.65M |
| Net Profit Margin | -9.29K% | -16.36K% | -25.74K% | -875.78% |
| Earnings Per Share | $-0.12 | $-0.32 | $-0.33 | $-0.30 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$2.1M | -$3.15M | -$2.98M | -$2.6M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.